However, from a collective analysis containing 15,828 older adults who were community-dwelling at baseline, those with high baseline IL-6 were 1.42 times more likely to develop global cognitive decline during a follow-up period of 2–7 years, compared to those with low IL-6. The gene discussed is IL6; the disease is Mental deterioration.